14-15 October | Boston Convention Center, MA
The leading Americas congress on drug and patient safety, convening C-suite, R&D, and data leaders to shape the future of pharmacovigilance, benefit-risk management, and the role of AI in transforming safety monitoring.
Find us at Booth #425 across both days.
Meet our speakers
Aman Wasan
Chief Executive Officer – ArisGlobal
- 14 October 2026 | 9:30am
Connected Intelligence: How Agentic AI Is Transforming Life Sciences Operations
Agentic AI is no longer a future concept—it is already delivering measurable value across pharmacovigilance and R&D operations. This keynote will explore how leading life sciences organizations are using AI-powered agents to streamline workflows, improve productivity, accelerate decision-making, and reduce operational burden across safety, regulatory, quality, and clinical functions. The guests will also discuss why connected data is essential to maximizing AI’s impact, enabling organizations to move beyond siloed processes and create a foundation for more intelligent, efficient, and scalable operations.
Ann-Marie Orange
Chief Information Officer & Global Head of R&D – ArisGlobal
- 15 October 2026 | 10:00am
Customer Panel: From Potential to Trusted Adoption: Scaling Agentic AI in Pharmacovigilance
As AI becomes increasingly embedded across pharmacovigilance, the conversation is shifting from experimentation to trust and operational adoption. In this panel discussion, PV leaders from leading pharmaceutical organizations will share how they are building confidence in AI within regulated environments and what it will take to move beyond 100% manual review of AI-generated outputs.
The discussion will explore governance, validation, performance monitoring, and human oversight, as well as the practical challenges of scaling AI while maintaining compliance, quality, and accountability.
